Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
16.2%
% of BMED's 115 holdings also in BBH
68.0%
% of BBH's 27 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 12.5% | 3.7% |
 |
ARGENX SE ADR | 3.3% | 5.1% | 3.3% |
|
BIO-TECHNE CORPORATION | 1.8% | 1.9% | 1.8% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 2.2% | 1.5% |
|
NATERA INC | 1.5% | 4.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to BBH
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
WATERS CORP | 2.0% |
BMED Underweight Relative to BBH
|
AMGEN INC | -14.8% |
|
VERTEX PHARMACEUTICALS INC | -10.9% |
|
GILEAD SCIENCES INC | -8.8% |
|
REGENERON PHARMACEUTICALS | -5.2% |
|
IQVIA HOLDINGS INC | -3.7% |
|
ICON PLC | -3.6% |
|
ALNYLAM PHARMACEUTICALS INC | -3.4% |
|
NATERA INC | -3.0% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
ILLUMINA INC | -2.7% |